Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for SHC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 54.44%
March 31, 2026 51.43%
December 31, 2025 53.68%
September 30, 2025 56.04%
June 30, 2025 53.45%
March 31, 2025 47.19%
December 31, 2024 51.34%
September 30, 2024 49.92%
June 30, 2024 49.67%
March 31, 2024 44.88%
December 31, 2023 52.99%
September 30, 2023 49.48%
June 30, 2023 48.37%
March 31, 2023 43.19%
Date Value
December 31, 2022 50.13%
September 30, 2022 48.37%
June 30, 2022 50.49%
March 31, 2022 47.74%
December 31, 2021 49.02%
September 30, 2021 48.51%
June 30, 2021 50.85%
March 31, 2021 46.58%
December 31, 2020 48.67%
September 30, 2020 46.32%
June 30, 2020 49.01%
March 31, 2020 43.53%
December 31, 2019 42.69%
September 30, 2019 43.93%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Ginkgo Bioworks Holdings, Inc. 30.37%
Natera, Inc. 63.70%
Myriad Genetics, Inc. 62.51%
Guardant Health, Inc. 65.39%
Quest Diagnostics, Inc. 32.53%

Gross Profit Margin (Quarterly) Related Metrics